Niacin And Niacinamide Market

By Form;

Powder, Granular, and Liquid

By Distribution Channel;

Pharmacies & Drug Stores, Hyper Markets & Super Market, and Others

By End Use;

Human Nutrition, Pharmaceuticals, Animal Nutrition, Cosmeceuticals, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn745984978 Published Date: August, 2025

Niacin and Niacinamide Market Overview

Niacin and Niacinamide Market (USD Million)

Niacin and Niacinamide Market was valued at USD 1,157.50 million in the year 2024. The size of this market is expected to increase to USD 1,717.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.8%.


Niacin And Niacinamide Market

*Market size in USD million

CAGR 5.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.8 %
Market Size (2024)USD 1,157.50 Million
Market Size (2031)USD 1,717.59 Million
Market ConcentrationMedium
Report Pages316
1,157.50
2024
1,717.59
2031

Major Players

  • Lonza Group AG
  • Koninklijke DSM N.V
  • Bactolac Pharmaceutical Inc
  • Merck KGaA
  • BASF SE
  • Foodchem International Corporation
  • Evonik Industries AG
  • Jubilant Life Sciences Limited
  • Vertellus Specialties Inc
  • Fagron NV

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Niacin And Niacinamide Market

Fragmented - Highly competitive market without dominant players


The Niacin and Niacinamide Market is expanding rapidly as supplement manufacturers and skincare brands introduce targeted formulations for metabolic and skin health. Around 65% of brand portfolios now include these ingredients to address wellness trends and efficacy expectations. Their role in promoting metabolic support and dermal rejuvenation continues to elevate market relevance and consumer adoption.

Wider Access Enabled by Strategic Partnerships
Close to 60% of brands have expanded product portfolios through mergers and partnerships with dermatology-focused companies and supplement distributors. These alliances streamline supply, marketing, and regulatory compliance. Through these strategic collaborations, companies are scaling distribution and integrating niacin-based solutions into broader wellness ecosystems.

Delivery Technology Elevating Performance Levels
Advancements in technological formulation — like microencapsulation and slow-release matrices — have improved ingredient stability and absorption by over 64%. These enhancements reduce side effects and elevate product efficiency. Smart delivery methods are enhancing consumer experience and setting new standards for niacin and niacinamide efficacy.

Strong Expansion Outlook Built on Innovation and Collaboration
With about 68% of health and skincare professionals endorsing niacinamide use, the segment’s future expansion appears secure. Investment in novel delivery platforms, clinically validated formulations, and co-branded product launches is shaping a promising growth trajectory. Continued innovation and partnerships will drive sustained adoption across nutrition, cosmeceutical, and therapeutic markets.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Form
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By End Use
    4. Market Snapshot, By Region
  4. Niacin and Niacinamide Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Focus on Health and Wellness
        2. Benefits of Niacin and Niacinamide
        3. Rising Healthcare Expenditure
      2. Restraints
        1. Side Effects of Niacin
        2. Availability of Substitutes
      3. Opportunities
        1. Innovation in Product Development
        2. Rising Demand in Emerging Markets
        3. Expanding Application Areas
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Niacin and Niacinamide Market, By Form, 2021 - 2031 (USD Million)
      1. Powder
      2. Granular
      3. Liquid
    2. Niacin and Niacinamide Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Pharmacies & Drug Stores
      2. Hyper Markets and Super Market
      3. Others
    3. Niacin and Niacinamide Market, By End Use, 2021 - 2031 (USD Million)
      1. Human Nutrition
      2. Pharmaceuticals
      3. Animal Nutrition
      4. Cosmeceuticals
      5. Others
    4. Niacin and Niacinamide Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Lonza Group AG
      2. Koninklijke DSM N.V
      3. Bactolac Pharmaceutical Inc
      4. Merck KGaA
      5. BASF SE
      6. Foodchem International Corporation
      7. Evonik Industries AG
      8. Jubilant Life Sciences Limited
      9. Vertellus Specialties Inc
      10. Fagron NV
  7. Analyst Views
  8. Future Outlook of the Market